Why the study?
Unrecognized EDTA-induced pseudothrombocytopenia can cause inappropriate clinical decisions compromising patient safety, yet expert recommendations for laboratory management remain scarce.
Answers are grounded in this paper and cite their sources.
These national recommendations provide a standardized laboratory workflow for identifying and managing EDTA-induced pseudothrombocytopenia to prevent inappropriate clinical decisions and ensure patient safety.
Pseudothrombocytopenia (PTCP) is defined by the occurence of spouriously low platelet count as a consequence of in vitro platelet aggregation.It is a rare and benign artifact, not associated with any specific disorder or therapy, that becomes clinically relevant when it is not timely and reliably recognized.Thus, it may result in inappropriate clinical decisions (i.e.unnecessary further testing, misdiagnoses and potential patients' mismanagement) unavoidably compromising patient safety.The most common form of PTCP is caused by ethylenediaminetetraacetic acid (EDTA).Several approaches for the management of samples with EDTA-induced PTCP have been described in the literature.However, expert recommendations are scarce.The scope of these recommendations is to assist in achieving national harmonisation in laboratory management (i.e.detecting and reporting platelet counts) of samples with EDTA-induced PTCP.These minimal recommendations were prepared by the members of the joint working group of the Croatian Chamber of Medical Biochemists and Working group for Laboratory Hematology of the Croatian Society of Medical Biochemistry and Laboratory Medicine, and might be customized according to specific conditions (i.e.personnel and equipment) of each individual laboratory.These recommendations are primarily intended to all laboratory professionals involved in the management of samples with EDTA-induced PTCP, but also to other healthcare professionals involved in collecting samples and interpreting complete blood count results.
No takes yet. Share an insight, caveat, or question.
Kopčinović et al. (2024) conducted a review in EDTA-induced pseudothrombocytopenia. Laboratory management of suspected EDTA-induced pseudothrombocytopenia was evaluated. National recommendations from Croatia outline a harmonized laboratory procedure for managing suspected EDTA-induced pseudothrombocytopenia, emphasizing peripheral blood smear inspection and reflex testing with 3.2% sodium citrate tubes.
Synapse has enriched 10 related papers. Consider them for comparative context: